Latest on ARWR：Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc
ArrowheadPharmaceuticalsInc.ARWR.O.OfficialDataPartner.LatestTrade.tradinghigher21.77USD.Change:0.38;%Change:+1.78%Positive.AsofNov8,2024.。其他文章還包含有：「ArrowheadPharmaceuticalsIncARWR」、「ArrowheadPharmaceuticals」、「ArrowheadPharmaceuticals」、「ArrowheadPharmaceuticals」、「ArrowheadResearchCorporation」、「ARWRStockPrice」、「ARWRStockQuotePriceandForecast」、「Newsroom」
查看更多 離開網站
Arrowhead Pharmaceuticals Inc ARWR
https://www.cnbc.com
Arrowhead Pharmaceuticals Inc ARWR:NASDAQ ; Open21.34 ; Day High21.92 ; Day Low21.00 ; Prev Close21.39 ; 52 Week High39.83 ...
Arrowhead Pharmaceuticals
https://finance.yahoo.com
Get the latest Arrowhead Pharmaceuticals, Inc. (ARWR) stock news and headlines to help you in your trading and investing decisions.
Arrowhead Pharmaceuticals
https://finance.yahoo.com
Find the latest Arrowhead Pharmaceuticals, Inc. (ARWR) stock quote, history, news and other vital information to help you with your stock trading and ...
Arrowhead Pharmaceuticals
https://www.nasdaq.com
Latest ARWR News · Markets. First Week of ARWR June 2025 Options Trading · Markets. Analysts Expect MDYG Will Reach $98 · Markets. Arrowhead Pharmaceuticals ...
Arrowhead Research Corporation
https://www.stocktitan.net
Arrowhead Pharmaceuticals (NASDAQ: ARWR) has announced the presentation of new Phase 3 clinical data from the PALISADE study of plozasiran (ARO-APOC3) at the ...
ARWR Stock Price
https://www.marketwatch.com
ARWR | Complete Arrowhead Pharmaceuticals Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
ARWR Stock Quote Price and Forecast
https://www.cnn.com
View Arrowhead Pharmaceuticals, Inc. ARWR stock quote prices, financial information, real-time forecasts, and company news from CNN.
Newsroom
https://arrowheadpharma.com
Arrowhead Pharmaceuticals presents new pivotal Phase 3 data at ESC 2024 from PALISADE study of Plozasiran in patients with familial Chylomicronemia syndrome.